Business
Change of Adviser
Change of Adviser.
About this update from Gattaca Plc
[{"type":"text","content":"\n \nRNS Number : 3100I Gattaca PLC 08 August 2019 \n\n8 August 2019\nGattaca plc(\"Gattaca\" or the \"Group\")\nAppointment of Liberum as Nominated Adviser & Broker\n \nGattaca plc (AIM: GATC), the UK's leading specialist Engineering and Technology staffing solutions business, is pleased to announce the appointment of Liberum Capital Limited (\"Liberum\") as its nominated adviser and sole broker with immediate effect.\n \n- ENDS -\n \nFor further information please contact: \n\n\n\nGattaca plc\n\n\n\n\n\n\n\nKevin Freeguard, Chief Executive Officer\n\n\n+44 (0)14 8989 8989\n\n\n\n\nSalar Farzad, Chief Financial Officer\n\n\n+44 (0)84 5166 1165\n\n\n\n\n\n\n\n\n\n\n\n\nLiberum Capital Limited (Nomad and Broker)\n\n\n\n\n\n\n\nBidhi Bhoma / Robert Morton / Euan Brown\n\n\n+44 (0)20 3100 2000\n\n\n\n\n\n\n\n\n\n\n\n\nCitigate Dewe Rogerson\n\n\n\n\n\n\n\nNick Hayns / Lucy Eyles / Claire Dansie\n\n\n+44 (0)20 7638 9571\n\n\n\n \nAbout Gattaca\nGattaca plc (LSE-AIM: GATC), is the UK's leading specialist Engineering and Technology, (IT & Telecoms) recruitment agency, providing contract, temporary and permanent staff. Established in 1984 and AIM-listed in 2006, the Group operates a well-balanced business model; consisting approximately 70% contract and 30% permanent.\nRecruiting in over 100 countries across the world from 13 offices in 7 countries, the Group has over 500 sales staff, with over 9,500 contractors on assignment and places 4,000 candidates into permanent positions each year.\nThe combined group is well-placed to take advantage of the convergence between Engineering, Technology and Telecoms skill sets and is now a specialist recruiter, of scale, in the UK and internationally.\n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END APPUGURARUPBGAM\n ","length":4875,"tagName":"div"}]